MYB and acute myeloid leukemia: Another intriguing mechanism of miR-155 in AML is driven by exosomes released by AML cells, which transport the miRNA to hematopoietic stem cells and progenitor cells; the release of miR-155 in these cells suppresses the hematopoietic functions by targeting the transcriptional activator MYB [141].